Search Within

Center for Hematologic Malignancies

Formats
  1. Journal Article (6190)
  2. Meeting Abstract (6164)
  3. Review (400)
  4. Book Section (216)
  5. Editorial (172)
  6. Research Letter (159)
  7. Guidelines (83)
  8. Conference Paper (70)
  9. Correspondence (61)
  10. Miscellaneous (19)
  11. Book Whole (10)
Groups
  1. Department of Medicine (11087)
  2. Hematologic Malignancies, Division of (10638)
  3. GSK Faculty (5447)
  4. Adult Leukemia (3721)
  5. Sloan Kettering Institute Faculty (3375)
  6. Hematologic Malignancies Research (3005)

More Groups

People
  1. Sergio Giralt (1069)
  2. Miguel-Angel Perales (944)
  3. Ross Levine (787)
  4. Andrew Zelenetz (785)
  5. Steven Horwitz (671)
  6. Martin Tallman (655)

More People

Years
  1. 2025 (308)
  2. 2024 (704)
  3. 2023 (877)
  4. 2022 (830)
  5. 2021 (802)
  6. 2020 (874)

More Years

Publications
  1. Blood (3413)
  2. Journal of Clinical Oncology (869)
  3. Biology of Blood and Marrow Transplantation (602)
  4. Clinical Lymphoma, Myeloma and Leukemia (304)
  5. Cancer Research (300)
  6. Haematologica (267)

More Publications

Publishers
  1. American Society of Hematology (3684)
  2. Elsevier Inc. (1668)
  3. Nature Publishing Group (1117)
  4. American Society of Clinical Oncology (918)
  5. American Association for Cancer Research (680)
  6. Wiley Blackwell (437)

More Publishers

Results (13544)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Characterizing the heterogeneity of Castleman disease and oligocentric subtype: Findings from the ACCELERATE registry
    Journal Article

    Pierson, S. K.; Brandstadter, J. D.; Torigian, D. A.; Bagg, A.; Lechowicz, M. J.; Alapat, D.; Casper, C.; Chadburn, A.; Chandrakasan, S.; Dispenzieri, A.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Allogeneic off-the-shelf CAR T-cell therapy for relapsed or refractory B-cell malignancies
    Journal Article

    Shahid, S.; Prockop, S. E.; Flynn, G. C.; Mauguen, A.; White, C. O.; Bieler, J.; McAvoy, D.; Hosszu, K.; Cancio, M. I.; Jakubowski, A. A.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Outcomes of older adults and frail patients receiving idecabtagene vicleucel: A CIBMTR study
    Research Letter

    Akhtar, O. S.; Oloyede, T.; Brazauskas, R.; Afrough, A.; Hashmi, H.; Sidana, S.; Ahmed, N.; Bye, M.; Hansen, D.; Ferreri, C.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Long-term outcomes with single-agent BRAF inhibitor therapy in Erdheim-Chester disease
    Research Letter

    Goyal, G.; Reiner, A. S.; Bossert, D.; Sigler, A. M.; Lacouture, M. E.; Rotemberg, V.; Francis, J. H.; Go, R. S.; Rampal, R. K.; Diamond, E. L.
    Blood (2025)

    Fulltext@MSK | Save
  • Clinical-genomic profiling of MDS to inform allo-HCT: Recommendations from an international panel on behalf of the EBMT
    Guidelines

    Gurnari, C.; Robin, M.; Adès, L.; Aljurf, M.; Almeida, A.; Duarte, F. B.; Bernard, E.; Cutler, C.; Della Porta, M. G.; De Witte, T.; more...
    Blood (2025)

    Fulltext@MSK | Save
  • Recycling is “bad to the bone” in patients with myeloma
    Editorial

    Miller, K. C.; Lesokhin, A. M.
    Blood (2025)

    Fulltext@MSK | Save
  • Risk factors associated with sub-optimal outcomes and hematotoxicity following obecabtagene autoleucel (obe-cel) for relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL)
    Meeting Abstract

    Sandhu, K. S.; Park, J. H.; Shaughnessy, P.; Logan, A. C.; Abedi, M.; Shah, B.; Bishop, M. R.; Deangelo, D. J.; Brugger, W.; Shang, J.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • Enhancing the persistence and anti-tumor efficacy of CAR-T and CAR-NK cells through genetic disruption of death receptors
    Meeting Abstract

    Cohen, T. D.; Yi, F.; Zumbo, P.; Etilib, R.; Arkin, H.; Gormally, M.; Hackett, C. S.; Kropp, K.; Etxeberria, I.; Chandran, S. S.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • PRC2-mediated apoptosis evasion is a therapeutic target of MDS/AML harboring inv(3)/t(3;3) and-7
    Meeting Abstract

    Kunimoto, H.; Honma, D.; Tsutsumi, S.; Sakuma, T.; Ohashi, T.; Teranaka, H.; Ikeda, J.; Toya, T.; Harada, Y.; Doki, N.; more...
    Cancer Science (2025)

    Fulltext@MSK | Save
  • Phase II study of responses to vaccination in pediatric cancer survivors following standard-of-care non-HSCT chemotherapy
    Journal Article

    Junak, S.; Steinherz, P. G.; Trippett, T.; Ruggiero, J.; Zakak, N.; Khakoo, Y.; Shukla, N.; Dunkel, I. J.; Kernan, N. A.
    Pediatric Blood and Cancer (2025)

    Fulltext@MSK | Save